BioSpace News Archive

Leading brand consultancy’s annual report ranks nation’s strongest health care brands

In advance of Melanoma Awareness Month, the Melanoma Research Alliance announced funding for 33 innovative research awards totaling $8.26 million.

Ophthalmology Times®, a leading multimedia platform dedicated to ophthalmologists, announces nominations are now open for the 2019 Resident Writers Award Program.

Meridian Bioscience, Inc. announced it has entered into a definitive agreement to acquire the business of GenePOC Inc., a Quebec City, Quebec, Canada based provider of molecular diagnostic instruments and assays.

CareCentrix, the leading provider of home-based post-acute care solutions, has added former Anthem executive, Ken Goulet, and current UnitedHealth Group and former Humana executive, Ken Fasola, as strategic advisors.

Safety, Tolerability and Comparative Bioavailability Data Support INP104, Impel’s Nasal Drug Candidate for Acute Migraine

New facility focuses on specialized drug discovery technologies and discovery research across gastrointestinal and neuroscience therapeutic areas

The global neuroendocrine tumors therapeutics market is expected to post a CAGR of close to 9% during the period 2019-2023, according to the latest market research report by Technavio.

The Quell Foundation remains committed to its mission to reduce the number of suicides, overdoses and, incarcerations of people with mental health illness. As a testament to achieving its mission, The Foundation is pleased to announce that it has distributed nearly $1.3 million to students across the country since its inception in 2016.

Capsule Technologies, Inc., a leader in medical device integration and non-critical care patient monitoring solutions, today announced it has acquired Bernoulli Health